GlassScriptPhysician profile
Jeffrey M Kufel
NPI 1437469723
$12,545.47
in general payments reported to CMS, 2019-2025
47 companies · $2,035 in 2025
The $2,035 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,449 · 2022: $2,817 · 2023: $2,171 · 2024: $2,074 · 2025: $2,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,279.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,613.80 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,242.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,077.88 | 2021-2025 | Farxiga, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $851.35 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $786.47 | 2021-2025 | Jardiance, Stiolto Respimat, Synjardy |
| Amgen INC. | $778.60 | 2021-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $730.29 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $608.01 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $564.90 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $465.65 | 2021-2024 | Xarelto |
| Sumitomo Pharma America, INC. | $412.28 | 2023-2025 | Gemtesa |
| Abbott Laboratories | $349.46 | 2021-2025 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $318.87 | 2021-2025 | |
| Pfizer INC. | $290.65 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $263.16 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kufel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.